We used ATP kit to detect changes in mitochondrial energy of liver cancer cells, and the results showed that compared with the control group, the ATP level of cells was reduced under sorafenib treatment, and the ATP level of liver cancer cells with silenced ORMDL3 was lower (Fig. S1 E). Here, ORMDL3 is linked to liver cancer.